Revolution in care of leukaemia as new treatment drug approved for cancer patients: Asciminib for Chronic myeloid leukaemia CML works differently to existing treatments, giving hope to patients who need a different approach. The charity Leukaemia Care today welcomes the news from the National Institute for Health and Care Excellence that a new cancer treatment […]
Read More… from Revolution in leukaemia care as new drug appoved





